Article
Molecular changes in the phosphatidylinositide 3-kinase (PI3K) pathway are common in gastric cancer.
Journal of surgical oncology - 1 Aug 2013
Tran Thang N, Brettingham-Moore Kate, Duong Cuong P, Mitchell Catherine, Clemons Nicholas J, Phillips Wayne A
Abstract excerpt
BACKGROUND AND OBJECTIVES: The phosphatidylinositide 3-kinase (PI3K) pathway is an important signalling pathway that is frequently activated in cancer cells. This has led to the emergence of PI3K inhibitors as potential new treatment modalities for many cancers. We have investigated the frequency of molecular changes in the PI3K pathway in gastric cancer. METHODS: A series of sixty one human gastric cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
